BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
Beverly A. Teicher. Immunotherapy for Gastrointestinal Cancer2017; : 79 doi: 10.1007/978-3-319-43063-8_4
Shigenobu Motoshima, Koji Yonemoto, Hideki Kamei, Michi Morita, Rin Yamaguchi. Prognostic implications of HER2 heterogeneity in gastric cancerOncotarget 2018; 9(10): 9262 doi: 10.18632/oncotarget.24265
Wei Zhu, Liang Ye, Jianzhao Zhang, Pengfei Yu, Hongbo Wang, Zuguang Ye, Jingwei Tian, Irina V Lebedeva. PFK15, a Small Molecule Inhibitor of PFKFB3, Induces Cell Cycle Arrest, Apoptosis and Inhibits Invasion in Gastric CancerPLOS ONE 2016; 11(9): e0163768 doi: 10.1371/journal.pone.0163768
Ying Fu, Hui Li, Xishan Hao. The self-renewal signaling pathways utilized by gastric cancer stem cellsTumor Biology 2017; 39(4): 101042831769757 doi: 10.1177/1010428317697577
Ling Qiu, Hui Yang, Gaochao Lv, Ke Li, Guiqing Liu, Wei Wang, Shanshan Wang, Xueyu Zhao, Minhao Xie, Jianguo Lin. Insights into the mevalonate pathway in the anticancer effect of a platinum complex on human gastric cancer cellsEuropean Journal of Pharmacology 2017; 810: 120 doi: 10.1016/j.ejphar.2017.06.035
Xiaofei Ni, Yanpeng Xing, Xuan Sun, Jian Suo. The safety and efficacy of anti-PD-1/anti-PD-L1 antibody therapy in the treatment of previously treated, advanced gastric or gastro-oesophageal junction cancer: A meta-analysis of prospective clinical trialsClinics and Research in Hepatology and Gastroenterology 2020; 44(2): 211 doi: 10.1016/j.clinre.2019.05.007
Minghui Zhang, Yuandi Dong, Haitao Liu, Yan Wang, Shu Zhao, Qijia Xuan, Yan Wang, Qingyuan Zhang. The clinicopathological and prognostic significance of PD-L1 expression in gastric cancer: a meta-analysis of 10 studies with 1,901 patientsScientific Reports 2016; 6(1) doi: 10.1038/srep37933